Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Self Abrading Rapidly Applied (SARA) Electrode Phase II

NCT02200523 is registered in ClinicalTrials.gov with Cleveland Medical Devices Inc as lead sponsor.

NCT NCT02200523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02200523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Self Abrading Rapidly Applied (SARA) Electrode Phase II
Lead sponsor
Cleveland Medical Devices Inc
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2014
Completion date
December 31, 2015
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

electroencephalographic variant pattern 1 (disorder)